Organization and description of business (Details Narrative) - USD ($) |
1 Months Ended | ||
---|---|---|---|
May 31, 2021 |
Sep. 30, 2021 |
Sep. 30, 2020 |
|
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||
Cash | $ 27,622,067 | $ 7,349,903 | |
Merger Agreement [Member] | Spin Off Entity [Member] | |||
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||
Payment made for spin-off transaction | $ 6,000,000.0 | ||
License Agreement [Member] | New Life Therapeutics PTE LTD [Member] | |||
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||
Proceeds from license fees | $ 1,000,000.0 | ||
License Agreement [Member] | New Life Therapeutics PTE LTD [Member] | Maximum [Member] | |||
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||
Future milestone payments | $ 20,000,000.0 |
X | ||||||||||
- Definition This amount refers to the payments for issuance of warrants spin-off transaction. No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Definition Cash received from licensees for license fees during the current period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|